Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phenylacetic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101830796B details a hydrolysis method for 3-ethyoxyl-4-carboxylphenylacetic acid. This route offers stable yields and simplified supply chain logistics for pharmaceutical manufacturers.
Patent CN101244994B details a safe, high-yield route for 2,4,5-trifluorophenylacetic acid via Willgerodt-Kindler reaction, offering significant cost and safety advantages for Sitagliptin production.
Novel patent route from natural anethole offers high purity and cost efficiency for pharmaceutical manufacturing, replacing toxic cyanide processes.
Patent CN114277020B reveals a novel nitrilase mutant for phenylacetic acid synthesis. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Discover a novel preparation method for 2,4,5-trifluorophenylacetic acid offering high purity and cost reduction in API manufacturing for global supply chains.
Patent CN101244994A details a high-purity synthesis route for 2,4,5-trifluorophenylacetic acid, offering significant supply chain and cost advantages for Sitagliptin manufacturing.
Patent CN117902972B reveals a clean four-step route for 2,4-dihydroxyphenylacetic acid, offering significant cost reduction and supply chain reliability for global buyers.
Novel metal oxide catalyzed decarboxylation route for Sitagliptin intermediate. High yield, low cost, scalable manufacturing for global supply chains.
Patent CN112851493A reveals a cost-effective route for Sitagliptin intermediates. Discover high-purity manufacturing and supply chain advantages.
Patent CN108686687B reveals novel Zn-Pd SiC catalyst for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Patent CN118026850B reveals continuous flow nitration reducing cold utility consumption and enhancing safety for dye intermediates manufacturing.
Novel dihalide-to-acid route eliminates toxic cyanide, offering cost-effective Repaglinide intermediate manufacturing with high purity.
Patent CN115536517B reveals high-yield synthesis reducing solvent waste. Enhances supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel chloromethylation route for Sitagliptin intermediate reduces waste and cost. High-purity 2,4,5-trifluorophenylacetic acid manufacturing with scalable green chemistry.
Patent CN116283541A reveals a novel route for m-hydroxyphenylacetic acid featuring MOM protection and ester rectification for superior purity and scalable manufacturing.
Discover a cost-effective, non-cyanide route for high-purity polymethoxy phenylacetic acid. Ideal for API synthesis like CA4 and Pterostilbene precursors.
Patent CN104370732B reveals a safer bromination method for clopidogrel intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN105517992B reveals stable crystalline forms for CaSR agonists. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN101717949B reveals green electrochemical route for p-vinylphenylacetic acid. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112441900B details a novel copper-catalyzed route for 4-felbinac. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.